ArticleKidney medicine2026

Safety, Pharmacokinetics, and Pharmacodynamics of SHR6508, a Calcium-Sensing Receptor Agonist, in Maintenance Hemodialysis Patients With Secondary Hyperparathyroidism: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Sijia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.